Jei Li

Jei Li has extensive experience in statistical programming and biostatistics, with a current role as a Biostatistical Programming Manager at Amgen since April 2022. Previously, at The Janssen Pharmaceutical Companies of Johnson & Johnson from April 2019 to March 2022, Jei Li worked as a Senior Statistical Programmer and Statistical Programmer Analyst, contributing to phase II-III neuroscience clinical drug trials and ensuring compliance with FDA regulatory requirements through the creation of eSubmission components. Tools utilized included all aspects of the SAS programming language and transformations of SDTM data into ADaM datasets. Additionally, Jei Li served as a Graduate Teaching Assistant at the University of Massachusetts Amherst for a biostatistics course and worked as a Research Analyst with DeltaQuest Foundation, Inc., analyzing clinical and demographic data. Educational qualifications include a Master’s Degree from the University of Massachusetts Amherst.